Search Results - Michael Blaeker
- Showing 1 - 2 results of 2
-
1
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study by Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš, Javier P. Gisbert, Geert D’Haens, Bu Hayee, Remo Panaccione, Hyun‐Soo Kim, Walter Reinisch, Helen E.J. Tyrrell, Young S. Oh, Swati Tole, Akiko Chai, Kirsten Chamberlain-James, Meina Tang, Stefan Schreiber, Nazimuddin Aboo, Tariq Ali Ahmad, Xavier Aldeguer Manté, Matthieu Allez, Sven Almér, Romain Altwegg, Montserrat Andreu García, Ramesh Arasaradnam, Sandro Ardizzone, Alessandro Armuzzi, Ian Arnott, Guy Aumais, Irit Avni‐Biron, Peter Barrow, Ian Beales, Fernando Bermejo San José, Abraham F. Bezuidenhout, Livia Biancone, Michael Blaeker, Stuart Bloom, Bernd Bokemeyer, Fabrizio Bossa, Peter Bossuyt, Guillaume Bouguen, Yoram Bouhnik, Gerd Bouma, Raymond Bourdages, Arnaud Bourreille, Christian Boustière, Tomáš Brabec, Stephan Brand, Carsten Buening, Anthony Buisson, Guillaume Cadiot, Xavier Calvet, Franck Carbonnel, Daniel Carpio, Jae Hee Cheon, Naoki Chiba, Camelia Chioncel, Nicoleta-Claudia Cimpoeru, Martin Clodi, Gino Roberto Corazza, R. Cosintino, José Cotter, Thomas Creed, Fraser Cummings, Silvio Danese, Gian Luigi De’ Angelis, Marc De Maeyer, Milind Y. Desai, Étienne Désilets, Pierre Desreumaux, Olivier Dewit, Geert D’Haens, Johanna Dinter, Ecaterina Daniela Dobru, Tomáš Douda, Dan L. Dumitrașcu, Matthias Ebert, Ana Echarri, Magdy Elkhashab, Chang Soo Eun, Brian G. Feagan, R Fejes, Catarina Fidalgo, Sigal Fishman, Bernard Flourié, Sharyle Fowler, Walter Fries, Csaba Fülöp, Mathurin Fuméry, G Kiss, Sonja Gassner, Daniel R. Gaya, Bastianello Germanà, Liliana Gheorghe, Cyrielle Gilletta, Paolo Gionchetti, Adrian-Eugen Goldis, Raquel Gonçalves, Jean–Charles Grimaud, T Gyökeres, Hervé Hagège
Published 2021Artigo -
2
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, cont... by Laurent Peyrin–Biroulet, Ailsa Hart, Peter Bossuyt, Millie D. Long, Matthieu Allez, Pascal Juillerat, Alessandro Armuzzi, Edward V. Loftus, Elham Ostad-Saffari, Astrid Scalori, Young S. Oh, Swati Tole, Akiko Chai, Jennifer Pulley, Stuart R. Lacey, William J. Sandborn, Humberto Aguilar, Tariq Ali Ahmad, Evangelos Akriviadis, Xavier Aldeguer Manté, Matthieu Allez, I Altorjay, Ashwin N. Ananthakrishnan, Vibeke Andersen, Montserrat Andreu García, Alessandro Armuzzi, Guy Aumais, Irit Avni‐Biron, Jeffrey Axler, Kamran Ayub, Filip Baert, Mauro Bafutto, George Bamias, Isaac Bassan, Curtis A. Baum, Laurent Beaugerie, Brian W. Behm, Pradeep Bekal, M. Catherine Bennett, Fernando Bermejo San José, Charles Bernstein, Dominik Bettenworth, Sudhir Bhaskar, Livia Biancone, Bahri M. Bilir, Michael Blaeker, Stuart Bloom, V. R. Bohman, Francisco Javier Bosques Padilla, Peter Bossuyt, Yoram Bouhnik, Gerd Bouma, Raymond Bourdages, Stephan Brand, Brian Bressler, Markus Brückner, Carsten Buening, Franck Carbonnel, Thomas C. Caves, Jonathon Chapman, Jae Hee Cheon, Naoki Chiba, Camelia Chioncel, Dimitrios Christodoulou, Martin Clodi, Albert Cohen, Gino Roberto Corazza, Richard Corlin, R. Cosintino, Fraser Cummings, Robin Dalal, Silvio Danese, Marc De Maeyer, Carlos F. Francesconi, Aminda De Silva, Henry Debinski, Pierre Desreumaux, Olivier Dewit, Geert D’Haens, Sandra Di Felice Boratto, Nik S. Ding, Tyler Dixon, Gerald W. Dryden, George Aaron Du Vall, Matthias Ebert, Ana Echarri, Robert Ehehalt, Magdy Elkhashab, Craig Ennis, Jason Etzel, Jan Fallingborg, Brian Feagan, R Fejes, Daniel Ferraz de Campos Mazo, Valéria Ferreira de Almeida e Borges, Andreas Fischer, Alan M. Fixelle, Mark R. Fleisher, Sharyle Fowler, B. Freilich
Published 2021Artigo
Search Tools:
Related Subjects
Disease
Gastroenterology
Internal medicine
Medicine
Tumor necrosis factor alpha
Ulcerative colitis
Alternative medicine
Chemistry
Chemotherapy
Dermatology
Double blind
Double blind study
Gardenia
Induction therapy
Infliximab
Maintenance therapy
Necrosis
Oncology
Organic chemistry
Pathology
Phase (matter)
Placebo
Randomized controlled trial
Surgery
Traditional Chinese medicine
Traditional medicine